RSCM

Rock Springs Capital Management Portfolio holdings

AUM $1.6B
This Quarter Return
+10.4%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$1.97B
AUM Growth
+$233M
Cap. Flow
+$156M
Cap. Flow %
7.95%
Top 10 Hldgs %
27.38%
Holding
158
New
16
Increased
48
Reduced
15
Closed
10

Top Buys

1
MDT icon
Medtronic
MDT
$35.5M
2
UNH icon
UnitedHealth
UNH
$27.6M
3
AET
Aetna Inc
AET
$25.5M
4
MRSN icon
Mersana Therapeutics
MRSN
$21.3M
5
TMO icon
Thermo Fisher Scientific
TMO
$19.2M

Top Sells

1
LLY icon
Eli Lilly
LLY
$27.3M
2
SHPG
Shire pic
SHPG
$24.2M
3
BMY icon
Bristol-Myers Squibb
BMY
$22.4M
4
AMGN icon
Amgen
AMGN
$16.1M
5
PTHN
Patheon N.V.
PTHN
$10.5M

Sector Composition

1 Healthcare 80.21%
2 Financials 3.81%
3 Consumer Discretionary 1.14%
4 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BAX icon
51
Baxter International
BAX
$12.1B
$13.9M 0.7%
+230,000
New +$13.9M
EHC icon
52
Encompass Health
EHC
$12.5B
$12.8M 0.65%
333,105
– –
ACRS icon
53
Aclaris Therapeutics
ACRS
$223M
$11.9M 0.6%
440,000
-235,000
-35% -$6.37M
ONC
54
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.5B
$11.9M 0.6%
265,000
– –
NVTA
55
DELISTED
Invitae Corporation
NVTA
$11.5M 0.58%
1,200,000
– –
SRGA
56
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$11.4M 0.58%
65,000
+3,000
+5% +$527K
BOLD
57
DELISTED
Audentes Therapeutics, Inc
BOLD
$11.4M 0.58%
595,200
+95,200
+19% +$1.82M
BMRN icon
58
BioMarin Pharmaceuticals
BMRN
$11.3B
$11.4M 0.57%
125,000
– –
DERM
59
DELISTED
Dermira, Inc.
DERM
$11.3M 0.57%
387,600
– –
RARX
60
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$11.2M 0.57%
600,000
-188,959
-24% -$3.54M
ARDX icon
61
Ardelyx
ARDX
$1.57B
$10.2M 0.52%
2,000,000
– –
RARE icon
62
Ultragenyx Pharmaceutical
RARE
$3.04B
$9.97M 0.5%
160,500
+750
+0.5% +$46.6K
CHRS icon
63
Coherus Oncology, Inc. Common Stock
CHRS
$146M
$9.96M 0.5%
693,900
+18,900
+3% +$271K
XENT
64
DELISTED
Intersect ENT, Inc
XENT
$9.64M 0.49%
345,000
– –
FGEN icon
65
FibroGen
FGEN
$48.4M
$9.04M 0.46%
11,200
+1,600
+17% +$1.29M
ASND icon
66
Ascendis Pharma
ASND
$12.1B
$9.02M 0.46%
325,000
– –
MDGL icon
67
Madrigal Pharmaceuticals
MDGL
$9.7B
$8.78M 0.44%
540,000
+315,000
+140% +$5.12M
CLSD icon
68
Clearside Biomedical
CLSD
$26.7M
$8.52M 0.43%
935,000
– –
TXMD icon
69
TherapeuticsMD
TXMD
$12.8M
$8.43M 0.43%
32,000
– –
ALNY icon
70
Alnylam Pharmaceuticals
ALNY
$58.6B
$8.38M 0.42%
+105,000
New +$8.38M
CO
71
DELISTED
Global Cord Blood Corporation
CO
$8.34M 0.42%
880,000
– –
ASMB icon
72
Assembly Biosciences
ASMB
$185M
$8.05M 0.41%
32,500
– –
INSM icon
73
Insmed
INSM
$30.3B
$8.03M 0.41%
468,000
– –
ACHN
74
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
$7.92M 0.4%
1,725,000
+225,000
+15% +$1.03M
REGN icon
75
Regeneron Pharmaceuticals
REGN
$59.8B
$7.86M 0.4%
16,000
+900
+6% +$442K
1 2
3
4 5